RANDOLPH CLOUD

EPIC Act, Intellectual Property, Most Favored Nations Drug Pricing, Medicare Part D, Medicaid, Pharmaceutical Manufacturing

Inflation Reduction Act, Intellectual Property, Most Favored Nations Drug Pricing, Medicare Part D, Medicaid, Pharmaceutical Manufacturing

Inflation Reduction Act, Intellectual Property, Medicare Part D, Medicaid, Pharmaceutical Manufacturing

Inflation Reduction Act, Drug Price Negotiation, 340B, PBM Reform, EPIC Act

Inflation Reduction Act, Drug Price Negotiation, 340B, PBM Reform, EPIC Act

Inflation Reduction Act, Drug Price Negotiation, 340B, PBM Reform, EPIC Act

Inflation Reduction Act, Drug Price Negotiation, 340B, PBM Reform, EPIC Act

Inflation Reduction Act, Drug Price Negotiation, 340B, PBM Reform

Inflation Reduction Act, Drug Price Negotiation, 340B, PBM

Inflation Reduction Act, Drug Price Negotiation, 340B, PBM

Inflation Reduction Act, Drug Price Negotiation, 340B, PBM

Non-interference, drug pricing, Medicare Parts B and D, innovation, clinical trials

Non-interference, drug pricing, Medicare Parts B and D, innovation, clinical trials

Non-interference, drug pricing, Medicare Parts B and D, innovation, clinical trials

Non-interference, drug pricing, Medicare Parts B and D, innovation, clinical trials

Non-interference, drug pricing, Medicare Parts B and D, innovation, clinical trials

Non-interference, drug pricing, Medicare Parts B and D, innovation, clinical trials

Intellectual property, Drug innovation, access to prescriptions, drug pricing

Foreign Reference Pricing, Anti-Microbial Resistance, Access to Prescription Drugs, Innovation, Vaccines

Foreign Reference Pricing, Anti-Microbial Resistance, Access to Prescription Drugs, Innovation, Vaccines

Foreign Reference Pricing, Anti-Microbial Resistance, Access to Prescription Drugs, Innovation, Vaccines

Medicare Part B and C, Patent and intellectual property, price controls and International Pricing Index, supply chain issues

Medicare Part B and C, Patent and intellectual property, price controls and International Pricing Index, supply chain issues

Medicare Part B and C, Patent and intellectual property, price controls and International Pricing Index, supply chain issues

Medicare Part B and C, Patent and intellectual property, price controls and International Pricing Index

Medicare Part B and C, Patent and intellectual property, price controls and International Pricing Index

Medicare Part B and C, Patent and intellectual property, price controls and International Pricing Index

Medicare Part B and C, Patent and intellectual property, price controls and International Pricing Index

Medicare Part B and C, Patent and intellectual property, price controls and International Pricing Index

Medicare, Independent Payment Advisory Board, Prescription Drug User Fee Act, Non-interference, importation of prescription drugs

Medicare, Independent Payment Advisory Board, Prescription Drug User Fee Act, Non-interference, importation of prescription drugs

Medicare, Independent Payment Advisory Board, Prescription Drug User Fee Act, Non-interference, importation of prescription drugs

Medicare, Independent Payment Advisory Board, Prescription Drug User Fee Act, Non-interference, importation of prescription drugs

Medicare, IPAB, PDUFA Re-authorization, Non-interference, importation of prescription drugs

Medicare, IPAB, PDUFA Re-authorization, Non-interference, importation of prescription drugs

Medicare, IPAB, PDUFA Re-authorization, Non-interference, importation of prescription drugs

Medicare, IPAB, PDUFA Re-authorization, Non-interference, importation of prescription drugs

Medicare Part D, Medicare Part B, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Maintenance and infrastructure for RDU Aiport

Maintenance and infrastructure for RDU Aiport

Maintenance and infrastructure of Raleigh-Durham Airport

Medicare Part D, Medicare Part B, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Maintenance and infrastructure for RDU Aiport

Maintenance and infrastructure of Raleigh-Durham Airport

Maintenance and infrastructure for RDU Aiport

Medicare Part D, Medicare Part B, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Medicare Part D, Medicare Part B, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Medicare Part D, Medicare Part B, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Medicare Part D, Medicare Part B, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Federal Funding for airport maintenance

Medicare Part D, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Medicare Part D, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Medicare Part D, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Medicare Part D, Trans-Pacific Partnership and Intellectual Property, Independent Payment Advisory Board Repeal, FDA regulation

Proposed CMS Rule Changes, Patent Reform Legislation, Medicare Part D, Trans Pacific Partnership

Proposed CMS Rule Changes, Patent Reform Legislation, Medicare Part D, Trans Pacific Partnership

Proposed CMS Rule Changes, Patent Reform Legislation, Medicare Part D, Trans Pacific Partnership,

Proposed CMS Rule Changes, Patent Reform Legislation, Medicare Part D, Trans Pacific Partnership

Independent Payment Advisory Board, Patent Reform Legislation, Medicare Part D, Trans Pacific Partnership

Independent Payment Advisory Board, Patent Reform Legislation, Medicare Part D, Trans Pacific Partnership

Independent Payment Advisory Board, Patent Reform Legislation, Medicare Part D, Trans Pacific Partnership

Independent Payment Advisory Board, Patent Reform Legislation, Medicare Part D, Trans Pacific Partnership

Air Quality Issues

Air Quality Issues

Air Quality Issues

Independent Payment Advisory Board, Patent Reform Legislation, Medicare Part D, Trans Pacific Partnership

Air Quality

Independent Payment Advisory Board, Patent Reform Legislation, Medicare Part D, Prescription Drug User Fee Act

Air Quality

Independent Payment Advisory Board, Patent Reform Legislation, Medicare Part D, PDUFA

Pollution control issues

Renewable Fuels, Energy Standards, Pollution

Independent Payment Advisory Board, Patent Reform Legislation, Medicare Part D

Patent Reform Legislation, Medicare Part D, Biologics Protections in Trans-Pacific Partnership Affiliated Organizations: http://www.phrma.org/member_company_list/

Patent Reform Legislation, Medicare Part D

EPA Rules, Air Quality Issues

EPA Rules, Air Quality Issues

Patent Reform Legislation, Medicare Part D

FDA Rules, Air Quality Issues

Patent Reform Legislation, Medicare Part D, Biologics Protections in Trans-Pacific Partnership Affiliated Organizations: http://www.phrma.org/member_company_list/

Support in Senate for Clean Air Act provisions

Independent Payment Advisory Board, Patent Reform Legislation, Medicare Part D INFORMATION UPDATE PAGE AFFILIATED ORGANIZATIONS: http://www.phrma.org/member_company_list/

Independent Payment Advisory Board and Patent Reform Legislation

Issues dealing with pharmaceutical innovation, patent protection, and Medicaid reimbursement being implemented or discussed in Congress PhRMA Members found here: http://www.phrma.org/member_company_list

Issues dealing with pharmaceutical innovation, patent protection, and Medicaid reimbursement duringly being implemented or discussed in Congress PhRMA Members found here: http://www.phrma.org/about_phrma/member_company_list/members

Health care reform issues and the implementation of the recently passed healthcare reform bill and the impact of the bio-pharmaceutical sector on the economy PhRMA Members found here: http://www.phrma.org/about_phrma/member_company_list/members

Follow on Biologics provisions in HR3590, HR1427, and HR1548, also Health Care and Education Reconcilation Act of 2010

America's Healthy Future Act of 2009- issues related to importation of pharmaceutical products from foreign countries. -H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval for follow-on biologics, including provisions on data exclusivity and patient procedures for biologics; -H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; -S. 726, Promoting Innovation and Access to Life-Saving Medicines Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics

Local economic impact of biopharmaceutical industry and Impact of Follow-on biologic legislation, Healthcare Reform issues before the Congress, including Sen. Max Baucus' America's Healthy Futures Act of 2009 and the developing proposals in the US House

H.R. 1427- Promoting Innovation and Access to Life-Saving Medicine Act : regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics (continued on separate page) H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.

Impact of medical innovation on the local economy and impact of Follow-on Biologic legislation on the pharmaceutical industry